Literature DB >> 16691006

An extraordinarily high level of IL-15 expression by a cell line transduced with a modified BMGneo vector displays hypoxic upregulation.

Xiang Q Huang1, Michael J Hamilton, Chung L Li, Chris Schmidt, Kay A Ellem.   

Abstract

Interleukin (IL)-15 expression level is tightly controlled in mammalian cells by various mechanisms. In order to achieve higher expression levels of IL-15, many attempts have been made, but the highest expression rate among those reported is still only 13.3 ng/106 cells/24 h. Here we report that a selected human embryonic kidney 293 (HEK293) cell line, denoted 293HAN cells, which can survive and proliferate under conditions of hypoxia, acidity, and nutritional depletion (HAN), after transduction -- with a modified BMGneo vector -- can produce functional human IL-15 at the extremely high rate of 890 ng/106 cells/24 h under normoxic conditions -- a 67-fold increase. This is as a result of multiple episomally based vector copy numbers per cell. An extra benefit was that the BMGneo vector was found to be inducible in hypoxia and allowed a further approximately threefold upregulation of the human IL-15 level which made these 293HAN cells, transduced with the modified BMGneo vector, a very promising tool for high IL-15 production (approximately 200-fold increase above that of baseline normoxia). The mechanism of hypoxic upregulation was found to be related to the mouse MT-1 promoter present in the vector.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691006     DOI: 10.1385/MB:33:1:49

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  22 in total

1.  Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1.

Authors:  B J Murphy; G K Andrews; D Bittel; D J Discher; J McCue; C J Green; M Yanovsky; A Giaccia; R M Sutherland; K R Laderoute; K A Webster
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

Review 2.  IL-15: the role of translational regulation in their expression.

Authors:  R N Bamford; A P Battiata; T A Waldmann
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

3.  Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2.

Authors:  Irina L Tourkova; Zoya R Yurkovetsky; Andrea Gambotto; Valeria P Makarenkova; Lori Perez; Levent Balkir; Paul D Robbins; Michael R Shurin; Galina V Shurin
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

4.  Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.

Authors:  Toru Shibata; Amato J Giaccia; J Martin Brown
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

5.  IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.

Authors:  J Marks-Konczalik; S Dubois; J M Losi; H Sabzevari; N Yamada; L Feigenbaum; T A Waldmann; Y Tagaya
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Characterization of the mouse metal-regulatory-element-binding proteins, metal element protein-1 and metal regulatory transcription factor-1.

Authors:  O Larochelle; G Stewart; P Moffatt; V Tremblay; C Séguin
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

7.  Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.

Authors:  C Y Kim; M H Tsai; C Osmanian; T G Graeber; J E Lee; R G Giffard; J A DiPaolo; D M Peehl; A J Giaccia
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

8.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

9.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Authors:  Rong Zeng; Rosanne Spolski; Steven E Finkelstein; SangKon Oh; Panu E Kovanen; Christian S Hinrichs; Cynthia A Pise-Masison; Michael F Radonovich; John N Brady; Nicholas P Restifo; Jay A Berzofsky; Warren J Leonard
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

10.  Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo.

Authors:  S Hazama; T Noma; F Wang; N Iizuka; Y Ogura; K Yoshimura; E Inoguchi; M Hakozaki; K Hirose; T Suzuki; M Oka
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more
  1 in total

1.  A homodimeric IL-15 superagonist F4RLI with easy preparation, improved half-life, and potent antitumor activities.

Authors:  Liangyin Lv; Hui Wang; Wenqiang Shi; Yang Wang; Wen Zhu; Zexin Liu; Xiaoqu Chen; Chen Zheng; Wencheng Kong; Wei Li; Jianwei Zhu; Huili Lu
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.